Skip to content
RDL Network logo
Supplementary Figure from Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib) — Allison Allen (2023) | RDL Network